Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 5,977 | 5,289 | 2,211 | 2,621 | 4,176 |
| Cost of Goods | 1,986 | 1,358 | 593 | 768 | 1,214 |
| Gross Profit | 3,991 | 3,931 | 1,618 | 1,853 | 2,962 |
| Operating Expenses | 12,346 | 13,202 | 16,017 | 13,787 | 11,521 |
| Operating Income | -7,369 | -8,913 | -13,806 | -11,166 | -8,345 |
| Interest Expense | 0 | 0 | -343 | 0 | 0 |
| Other Income | -779 | 1,057 | -2,168 | 483 | 3,160 |
| Pre-tax Income | -8,148 | -7,856 | -15,631 | -10,683 | -5,185 |
| Income Tax | 26 | 121 | 64 | 41 | -238 |
| Net Income Continuous | -8,174 | -7,977 | -15,695 | -10,724 | -4,947 |
| Net Income | $-8,174 | $-7,977 | $-15,695 | $-10,724 | $-4,947 |
| EPS Basic Total Ops | -0.27 | -0.26 | -0.52 | -0.36 | -0.19 |
| EPS Basic Continuous Ops | -0.26 | -0.27 | -0.52 | -0.36 | -0.19 |
| EPS Diluted Total Ops | -0.27 | -0.26 | -0.52 | -0.36 | -0.19 |
| EPS Diluted Continuous Ops | -0.26 | -0.27 | -0.52 | -0.36 | -0.19 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.26 | -0.52 | -0.36 | -0.20 |
| EBITDA(a) | $-7,260 | $-8,766 | $-13,665 | $-11,003 | $-8,107 |